Published in Virus Res on January 20, 2013
Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice. J Virol (2017) 0.78
Roles of Us8A and Its Phosphorylation Mediated by Us3 in Herpes Simplex Virus 1 Pathogenesis. J Virol (2016) 0.76
Deletion of a Predicted β-Sheet Domain within the Amino Terminus of Herpes Simplex Virus Glycoprotein K Conserved among Alphaherpesviruses Prevents Virus Entry into Neuronal Axons. J Virol (2015) 0.76
Genetic characterization of human herpesvirus type 1: Full-length genome sequence of strain obtained from an encephalitis case from India. Indian J Med Res (2016) 0.75
Viral forensic genomics reveals the relatedness of classic herpes simplex virus strains KOS, KOS63, and KOS79. Virology (2016) 0.75
Differentiated SH-SY5Y human cells provide a reductionist model of HSV-1 neurotropism. J Virol (2017) 0.75
A model of genital herpes simplex virus Type 1 infection in Rhesus Macaques. J Med Primatol (2017) 0.75
Temperature-sensitive mutants of herpes simplex virus type 1: isolation, complementation and partial characterization. Virology (1973) 5.10
RELATIONSHIP BETWEEN THE ENVELOPE AND THE INFECTIVITY OF HERPES SIMPLEX VIRUS. Proc Soc Exp Biol Med (1964) 4.78
Genital herpes. Lancet (2007) 3.83
Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A (2004) 3.74
Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J Virol (1995) 2.52
Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS. J Virol (1986) 2.41
Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis. J Virol (1995) 2.26
Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect Immun (1983) 2.21
The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol (1998) 2.18
Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge. Virology (1998) 1.86
Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J Virol (2003) 1.83
Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits. Curr Eye Res (1987) 1.70
An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation. J Virol (1995) 1.54
Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation. Invest Ophthalmol Vis Sci (1991) 1.47
Reactivation of latent infection and induction of recurrent herpetic eye disease in mice. J Gen Virol (1990) 1.46
Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol (2003) 1.45
Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. J Virol (1994) 1.42
EXPERIMENTAL INDUCTION OF DISCIFORM KERATITIS. Arch Ophthalmol (1965) 1.40
Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system. J Virol (1994) 1.30
Reactivation of murine latent HSV infection by epinephrine iontophoresis. Invest Ophthalmol Vis Sci (1984) 1.27
Spontaneous ocular shedding of HSV-1 in latently infected rabbits. Invest Ophthalmol Vis Sci (1985) 1.18
Host species and strain differences affect the ability of an HSV-1 ICP0 deletion mutant to establish latency and spontaneously reactivate in vivo. Virology (1990) 1.17
Genome sequence of herpes simplex virus 1 strain KOS. J Virol (2012) 1.12
Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol (2011) 1.09
Herpes simplex virus type 1 mutants containing the KOS strain ICP34.5 gene in place of the McKrae ICP34.5 gene have McKrae-like spontaneous reactivation but non-McKrae-like virulence. J Gen Virol (2002) 1.09
Phosphorylation of arabinofuranosylthymine in non-infected and herpesvirus (TK+ and TK-)-infected cells. J Gen Virol (1979) 1.06
Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States. J Clin Microbiol (2009) 1.05
Role of polymorphonuclear leukocytes in resolution of HSV-2 infection of the mouse vagina. J Reprod Immunol (2001) 1.03
Mapping neuroinvasiveness of the herpes simplex virus type 1 encephalitis-inducing strain 2762 by the use of monoclonal antibodies. Mol Cell Probes (1992) 1.00
Recurrence phenotypes and establishment of latency following rabbit keratitis produced by multiple herpes simplex virus strains. J Gen Virol (1983) 0.99
The herpes simplex virus type 1 (HSV-1) glycoprotein K(gK) is essential for viral corneal spread and neuroinvasiveness. Curr Eye Res (2008) 0.99
Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes. Can J Public Health (2011) 0.96
A structural and functional comparison of the latency-associated transcript promoters of herpes simplex virus type 1 strains KOS and McKrae. J Gen Virol (1994) 0.96
Selective ablation of virion host shutoff protein RNase activity attenuates herpes simplex virus 2 in mice. J Virol (2008) 0.95
Transgenic reporter mouse for bioluminescence imaging of herpes simplex virus 1 infection in living mice. Virology (2006) 0.93
Herpes simplex virus type 1 is the main cause of genital herpes in women of Natal, Brazil. Eur J Obstet Gynecol Reprod Biol (2012) 0.92
Trends in herpes simplex virus type 1 and 2 infections among patients diagnosed with genital herpes in a Finnish sexually transmitted disease clinic, 1994-2002. Sex Transm Dis (2007) 0.90
American College Health Association annual Pap test and sexually transmitted infection survey: 2006. J Am Coll Health (2008) 0.89
Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cells. Virology (2008) 0.88
Genome sequence of herpes simplex virus 1 strain McKrae. J Virol (2012) 0.88
Neurokinin 1 receptor signaling affects the local innate immune defense against genital herpes virus infection. J Immunol (2005) 0.88
Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system. Eur J Clin Microbiol Infect Dis (1990) 0.87
Increase of genital HSV-1 and mixed HSV-1 and HSV-2 infection in Bangkok, Thailand. J Med Assoc Thai (2005) 0.87
Sequence and comparative analysis of the genome of HSV-1 strain McKrae. Virology (2012) 0.83
Rapid spread of a neurovirulent strain of HSV-1 through the CNS of BALB/c mice following anterior chamber inoculation. J Neurovirol (2002) 0.83
Virus-encoded b7-2 costimulation molecules enhance the protective capacity of a replication-defective herpes simplex virus type 2 vaccine in immunocompetent mice. J Virol (2008) 0.82
B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient mice. J Virol (2007) 0.81
Comparison of the host immune response to herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites. J Virol (2012) 0.81
Herpes simplex virus infection in a university health population: clinical manifestations, epidemiology, and implications. J Am Coll Health (2010) 0.81
Impaired induction of protective immunity by highly virulent herpes simplex virus type 2 in a murine model of genital herpes. Arch Virol (2000) 0.80
Asymptomatic vaginal herpes simplex virus infections in mice: virology and pathohistology. Arch Virol (1996) 0.76
Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol (2003) 1.45
Pathogenesis of herpes simplex virus type 2 virion host shutoff (vhs) mutants. J Virol (2002) 1.39
Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness. Virology (2004) 1.24
Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state. J Virol (2008) 1.18
Genome sequence of herpes simplex virus 1 strain KOS. J Virol (2012) 1.12
CD8(+) T cells control corneal disease following ocular infection with herpes simplex virus type 1. J Gen Virol (2004) 1.09
Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol (2006) 1.08
Innate immunity to herpes simplex virus type 2. Viral Immunol (2003) 1.06
Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection. J Virol (2002) 1.04
Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice. J Gen Virol (2002) 1.02
Selective ablation of virion host shutoff protein RNase activity attenuates herpes simplex virus 2 in mice. J Virol (2008) 0.95
HSV-1 ICP0: paving the way for viral replication. Future Virol (2011) 0.94
Herpes simplex virus 2 UL13 protein kinase disrupts nuclear lamins. Virology (2009) 0.93
Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation. J Virol (2003) 0.91
Role of nuclear factor Y in stress-induced activation of the herpes simplex virus type 1 ICP0 promoter. J Virol (2010) 0.89
Transient expression of herpes simplex virus type 1 ICP22 represses viral promoter activity and complements the replication of an ICP22 null virus. J Virol (2009) 0.89
B7 costimulation plays an important role in protection from herpes simplex virus type 2-mediated pathology. J Virol (2002) 0.88
Herpes simplex virus 2 VP22 phosphorylation induced by cellular and viral kinases does not influence intracellular localization. Virology (2004) 0.88
Genome sequence of herpes simplex virus 1 strain McKrae. J Virol (2012) 0.88
Deletion of the herpes simplex virus 1 UL49 gene results in mRNA and protein translation defects that are complemented by secondary mutations in UL41. J Virol (2012) 0.87
N-terminal phosphorylation sites of herpes simplex virus 1 ICP0 differentially regulate its activities and enhance viral replication. J Virol (2012) 0.86
hTERT extends the life of human fibroblasts without compromising type I interferon signaling. PLoS One (2013) 0.84
Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNase L. Virology (2006) 0.83
Substrate specificity of the herpes simplex virus type 2 UL13 protein kinase. Virology (2008) 0.83
Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation. J Virol (2011) 0.83
CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β. Antiviral Res (2011) 0.82
Virus-encoded b7-2 costimulation molecules enhance the protective capacity of a replication-defective herpes simplex virus type 2 vaccine in immunocompetent mice. J Virol (2008) 0.82
A proautophagic antiviral role for the cellular prion protein identified by infection with a herpes simplex virus 1 ICP34.5 mutant. J Virol (2013) 0.81
B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient mice. J Virol (2007) 0.81
B7 costimulation molecules encoded by replication-defective, vhs-deficient HSV-1 improve vaccine-induced protection against corneal disease. PLoS One (2011) 0.81
HSV-1 ICP22: hijacking host nuclear functions to enhance viral infection. Future Microbiol (2013) 0.80
Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replication in vivo. J Neurovirol (2010) 0.78
Herpes simplex virus 1 ICP22 but not US 1.5 is required for efficient acute replication in mice and VICE domain formation. J Virol (2013) 0.78
A flow cytometric assay for the study of E3 ubiquitin ligase activity. Cytometry A (2009) 0.75